WHO releases new guidelines for simplified treatment of common mental disorders

Millions of people with common, but untreated, mental, neurological and substance use disorders can now benefit from new simplified diagnosis and treatment guidelines released today by WHO. The guidelines are designed to facilitate the management of depression, alcohol use disorders, epilepsy and other common mental disorders in the primary health-care setting.

The Intervention guide extends competence in diagnosis and management to non-mental health specialists including doctors, nurses and other health providers. These evidence-based guidelines are presented as flow charts to simplify the process of providing care in the primary health-care setting.

"In a key achievement, the Intervention guide transforms a world of expertise and clinical experience, contributed by hundreds of experts, into less than 100 pages of clinical wisdom and succinct practical advice," says Dr Margaret Chan, Director-General of the World Health Organization.

Almost 95 million people with depression do not receive any treatment or care

The WHO estimates that more than 75% of people with mental, neurological and substance use disorders -- including nearly 95 million people with depression and more than 25 million people with epilepsy -- living in developing countries do not receive any treatment or care. Placing the ability to diagnose and treat them into the primary health care system will significantly increase the number of people who can access care.

Expensive technologies are not required to improve mental health services

"Improvement in mental health services doesn't require sophisticated and expensive technologies. What is required is increasing the capacity of the primary health care system for delivery of an integrated package of care," says Dr Ala Alwan, Assistant Director-General for Noncommunicable Diseases and Mental Health at WHO.

An estimated one in four people globally will experience a mental health condition in their lifetime. People with mental, neurological and substance use disorders are often stigmatized and subject to neglect and abuse. The resources available are insufficient, inequitably distributed and inefficiently used. In the majority of countries, less than 2% of health funds are spent on mental health. As a result, a large majority of people with these disorders receive no care at all.

Implementing the guidelines

WHO in collaboration with partners will provide technical support to countries to implement the guidelines and has already initiated the programme for scaling up care in six countries; Ethiopia, Jordan, Nigeria, Panama, Sierra Leone and Solomon Islands.

How the programme will help people

"The programme will lead to nurses in Ethiopia recognizing people suffering with depression in their day to day work and providing psychosocial assistance. Similarly, doctors in Jordan and medical assistants in Nigeria will be able to treat children with epilepsy," says Dr Shekhar Saxena, Director of the Department of Mental Health and Substance Abuse at WHO. "Both these conditions are commonly encountered in primary care, but neither identified nor treated due to lack of knowledge and skills of the health care providers."

The Intervention guide will help scale up care for mental, neurological and substance use disorders - which is the aim of WHO mental health Gap Action Programme (mhGAP). Multiple partners including Member States, UN agencies, research institutes, universities, multilateral agencies, foundations, WHO Collaborating Centres and NGOs under the (mental health Gap Action Programme (mhGAP) Forum have agreed to assist WHO in advocating for improving mental health care and services in developing countries.

WHO through its mhGAP programme, calls on governments, donors and mental health stakeholders to rapidly increase funding and basic mental health services to close the huge treatment gap.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes medication shows promise in reducing alcohol use